In endometrial cancer tissues, VEGF expression is associated with elevated tumor vascularization as measured by microvessel density (3), and is a predictive marker for decreased 5-year survival in patients with advanced endometrial carcinoma (21–23). This evidence concerns the gene VEGFA and neoplasm.